China Universal Asset Management Company’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-13,676
| Closed | -$50.3K | – | 526 |
|
2024
Q3 | $50.3K | Buy |
13,676
+5,333
| +64% | +$19.6K | 0.01% | 386 |
|
2024
Q2 | $34.1K | Sell |
8,343
-5,291
| -39% | -$21.6K | ﹤0.01% | 377 |
|
2024
Q1 | $215K | Buy |
13,634
+5,446
| +67% | +$85.8K | 0.03% | 280 |
|
2023
Q4 | $124K | Buy |
8,188
+6,379
| +353% | +$96.6K | 0.02% | 254 |
|
2023
Q3 | $36.3K | Buy |
1,809
+1,030
| +132% | +$20.7K | 0.01% | 251 |
|
2023
Q2 | $22K | Buy |
779
+6
| +0.8% | +$169 | 0.01% | 257 |
|
2023
Q1 | $13.3K | Buy |
773
+194
| +34% | +$3.34K | ﹤0.01% | 260 |
|
2022
Q4 | $11.7K | Buy |
579
+45
| +8% | +$906 | ﹤0.01% | 213 |
|
2022
Q3 | $12K | Buy |
+534
| New | +$12K | 0.01% | 189 |
|